Physician profile
Eva Wu
NPI 1184183030
$3,953.44
in general payments reported to CMS, 2019-2025
12 companies · $155 in 2025
The $155 reported for 2025 was more than what a typical provider received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $39.57 · 2021: $17.19 · 2022: $1,730 · 2023: $852 · 2024: $1,159 · 2025: $155.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,167.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,166.62 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $2,927.48 | 2022-2024 | Serrato, Everest Spinal System, Core |
| Globus Medical, INC. | $274.47 | 2023-2024 | Reline, Altera, Xlif |
| Si-Bone, INC. | $192.29 | 2024 | |
| Nuvasive, INC. | $123.30 | 2023 | Xlif |
| Medical Device Business Services, INC. | $118.98 | 2024-2025 | Symphony |
| Icotec Medical INC. | $86.50 | 2025 | Kong-Tl Vbr, End Plate, Round, L and Screw, 12 X 43 Mm, Kong-Tl Vbr, End Plate, Rectangular, M and Screw, 12 X 33 Mm, Vader Pedicle System, Rod, Carbon/Peek, Curved, 6.0 R450 X 200 Mm |
| Medtronic, INC. | $57.42 | 2024 | Midas Rex |
| Integra Lifesciences Corporation | $44.22 | 2021-2022 | |
| Osteomed LLC | $39.57 | 2020 | |
| Depuy Synthes Sales INC. | $34.07 | 2024 | Na |
| Silk Road Medical, INC. | $33.86 | 2023 | Enroute Transcarotid Stent, Enroute Transcarotid Neuroprotection System |
| Ucb, INC. | $21.28 | 2023 | Briviact |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eva Wu listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.